20523 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence
#602PROCESS FOR THE REMOVAL AND RECOVERY OF HESPERALOE EXTRACTIVES
#603METHOD AND COMPOSITION FOR PRODUCTION OF A PHYTONUTRIENT IN A MICROBIOME
#604TREATMENT OF ATRIAL DYSFUNCTION
#605ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS
#606COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING RADIATION-INDUCED BYSTANDER EFFECTS CAUSED BY RADIATION OR RADIOTHERAPY
#607ANTIVIRAL COMPOUNDS AND METHODS OF USING THE SAME
#608NON-ACTIVATED, AMORPHOUS, pH NEUTRAL, TWO-PART BEDSIDE-READY CLAY DELIVERY SYSTEM THAT TREATS PATHOGEN INFECTIONS IN HUMANS AND ANIMALS
#609Treatments of prostate cancer
#610LOW DOSE TOPIRAMATE/PHENTERMINE COMPOSITION AND METHODS OF USE THEREOF
#611NOVEL TRANSDUCTION ENHANCERS AND USES THEREOF
#612PTEN inhibitors for treatment and prevention of bone marrow loss
#613ANTIFUNGAL PRODRUGS
#614KILLING SENESCENT CELLS AND TREATING SENESCENCE-ASSOCIATED CONDITIONS USING A SRC INHIBITOR AND A FLAVONOID
#615METHODS FOR TREATING OR PREVENTING CHRONIC KIDNEY DISEASE
#616Methods for continuous manufacture of liposomal drug products
#617DRUG AND DIAGNOSTIC COMBINATION SYSTEM TO IDENTIFY AND TREAT SINGLE-STRANDED RNA VIRUSES INCLUDING CORONAVIRUSES AND MONKEYPOX
#618Formulations and methods for treating conditions of the eye
#619A Composition for Management of COVID-19 and Associated Disorders
#620COMPOSITION FOR AMELIORATION, PREVENTION OR TREATMENT OF HAIR LOSS, COMPRISING CATECHIN 7-O-beta-D-APIOFURANOSIDE AS ACTIVE INGREDIENT
#621NANOSYSTEMS AS SELECTIVE VEHICLES
#622PHARMACEUTICAL COMPOSITIONS AND USES THEREOF IN TREATING MUSCLE ATROPHY
#623Pharmaceutical compositions and uses thereof in treating Parkinson's disease
#624METHODS FOR ENHANCING SLEEP QUALITY
#625Agent for Improving Symptoms of Menopause
#626Enhanced caffeinated beverage composition
#627COMPOSITIONS AND METHODS FOR PREDICTING THERAPEUTIC OUTCOME
#628DRUG COMBINATION FOR TREATING DIABETES MELLITUS AND COMPLICATIONS THEREOF AND PHARMACEUTICAL COMPOSITION OF DRUG COMBINATION
#629DRUG DELIVERY SYSTEM BASED ON CALCIUM PHOSPHATE NANOPARTICLES FUNCTIONALIZED WITH BIOACTIVE COMPOUNDS FROM EUPHORBIA EXTRACT AND THE USES THEREOF
#630MAIN AGENT UNIFORMLY DISPERSED MICROSPHERE AND A SUSTAINED RELEASE FORMULATION COMPRISING THE SAME
#631A TOPICAL ANTIBIOTIC CONTAINING PHARMACEUTICAL COMPOSITION FOR BACTERIAL INFECTIONS AND WOUND HEALING
#632Compositions and methods for dengue virus chimeric constructions in vaccines
#633AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING GENETIC DISORDERS
#634OLEOGEL AND OLEOPASTE COMPOSITIONS AND USES THEREOF
#635ANTIBIOTIC AND ANTI-INFLAMMATORY COMPOSITIONS AND METHODS OF USE
#636USE OF COMPOUNDS FOR TREATING VIRAL INFECTIONS
#637USE OF ASTRAGALUS MEDICINAL COMPOSITION FOR PREPARING DRUG FOR ENHANCING CANCER THERAPY
#638APPLICATION OF COMPOUNDS IN CONTROLLING OR KILLING MITES
#639METHODS FOR SOLID TUMOR TREATMENT
#640THERAPEUTIC METHODS FOR PREVENTING TUMOR METASTASIS AND TUMOR RECURRENCE
#641APPLICATION OF RADIX GENTIANAE MACROPHYLLAE AND MONOMER COMPOUND THEREOF IN KILLING MITES
#642METHOD AND COMPOSITION FOR TREATING ALZHEIMERS
#643INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR TREATING CORONARY DISORDERS
#644Compositions comprising a serotonergic tryptamine compound
#645Carbonic anhydrase enzymes for regulating mast cell hematopoiesis and type 2 inflammation
#646PREPARATION FOR USE AS ANTIOXIDANT
#647COMBINATIONS OF NANOPARTICLE-ENCAPSULATED CARGO ENTITIES AND METHODS FOR MAKING AND USING SAME
#648Theacrine-based supplement and method of use thereof in a synergistic combination with caffeine
#649NOVEL PROCESS
#650COMPOSITION FOR PREVENTING OR TREATING CARDIOVASCULAR AND METABOLIC DISEASES COMPRISING ELAEOCARPUS PETIOLATUS
#651THE APPLICATION OF ALOESIN IN THE PREPARATION OF PRODUCTS FOR PREVENTING OR TREATING OBESITY
#652PHARMACEUTICAL COMPOSITIONS OF A THERAPEUTIC POLYENE MACROLIDE AND METHODS OF THEIR USE
#653IMMUNOMODULATING TRIFLUOROMETHYL-AMINAL AZALIDES
#654Bacterial DNA gyrase inhibitors and methods of use thereof
#655IMMUNOMODULATING O-HET/ARYL AZALIDES
#656PYRAZINE COMPOUNDS AND USES THEREOF
#657LIPID-BASED COMPOSITIONS OF ANTIINFECTIVES FOR TREATING PULMONARY INFECTIONS AND METHODS OF USE THEREOF
#658Methods of treating ovarian cancer with hemp extract
#659BIOCONVERSION OF OLEUROPEIN
#660Methods of treating endometrial cancer using hemp extract
#661PARIS POLYPHYLLA SAPONIN EXTRACT WITH ACTIVITY AGAINST MULTIDRUG-RESISTANT BACTERIA AND PREPARATION AND USE THEREOF
#662COMPOSITIONS AND METHODS FOR THE TREATMENT OF TOXIC GAS EXPOSURE
#663MEANS AND METHODS FOR ENHANCING CANNABINOIDS EFFICACY
#664ANTI-OBESITY COMPOSITION AND COMPOSITION FOR ORAL ADMINISTRATION
#665COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTRACELLULAR BACTERIAL INFECTIONS
#666TRACELESS LINKERS AND PROTEIN-CONJUGATES THEREOF
#667USES OF TAXIFOLIN FOR RESPIRATORY HEALTH
#668PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER CONTAINING, AS ACTIVE INGREDIENT, COMPLEX OF BIGUANIDE-BASED COMPOUND AND FLAVONE, HYDROXYFLAVONE, FLAVANONE, FLAVONE DERIVATIVE, HYDROXYFLAVONE DERIVATIVE, OR FLAVANONE DERIVATIVE
#669PHARMACEUTICAL COMPOSITION COMPRISING PROTEIN KINASE INHIBITOR AND CHEMOTHERAPEUTIC DRUG AND USE THEREOF
#670Collagenase Activity Inhibitor
#671Pemafibrate dosing regimens
#672THE COMBINATION OF CYCLIN DEPENDENT KINASE 7 INHIBITOR AND IMMUNOTHERAPY FOR TREATMENT OF CANCER
#673HIF-1 ACTIVATOR
#674FIBROTIC DISEASE MECHANISM AND THERAPEUTIC DRUG THEREFOR
#675CORONAVIRIDAE INFECTION AND AVERMECTINS
#676METHODS FOR THE TREATMENT OF HEADACHE DISORDERS
#67714-MEMBERED KETOLIDES AND METHODS OF THEIR PREPARATION AND USE
#678Methods of oral administration of protocatechuic acid for treating or reducing the severity of a joint injury or disease
#679Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)
#680Pharmaceutical composition for preventing or treating wound, comprising indirubin derivative as active ingredient
#681COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION OF ANTIBIOTICS
#682HERBAL PREPARATION FOR PREVENTION AND TREATMENT OF HELICOBACTER PYLORI INFECTION
#683FORMULATIONS OF POLYBASIC DRUGS TO REDUCE MULTI-ORGAN TOXICITY
#684Composition And Method for Modulating Hydrogen Ion Physiology Related to Weight Loss and Metabolism
#6853CLPRO-TARGETING PHILLYRIN, DERIVATIVE THEREOF, AND USE THEREOF AGAINST NOVEL CORONAVIRUS
#686COMPOSITION AND METHOD FOR MODULATING HYDROGEN ION PHYSIOLOGY RELATED TO BRAIN HEALTH COMPONENT
#687IMIDAZOLE-BASED SYNTHETIC LIPIDOIDS FOR IN VIVO MRNA DELIVERY INTO IMMUNE CELLS
#688Use of Albiflorin in Treatment of Coronavirus Pneumonia
#689METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS
#690ANTIBODIES THAT DISRUPT THE INTERACTION OF GAL3 AND INSULIN RECEPTOR OR INTEGRINS AND METHODS OF USE THEREOF
#691COMPOSITION AND FUNCTIONAL FOOD PRODUCT COMPRISING GREEN TEA EXTRACT
#692BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
#693NOVEL COMPOSITION
#694USE OF DOXYCYCLINE, RESVERATROL, IVERMECTIN, AND RELATED CHEMICALLY MODIFIED COMPOUNDS TO TREAT OR PREVENT VIRAL INFECTIONS
#695INHIBITORS OF MHC-I NEF DOWNMODULATION FOR TREATING HIV
#696PARASITICIDAL COMPOSITIONS COMPRISING AN ISOXAZOLINE ACTIVE AGENT, METHODS AND USES THEREOF
#697COMPOSITION OF SUSPOEMULSION FORMULATION OF ANTHELMINTIC DRUGS WITH ESSENTIAL OILS FOR NASO-PULMONARY ADMINISTRATION
#698GLUCOPYRANOSYL DERIVATIVES AND THEIR USES
#699IVERMECTIN COMPOSITIONS FOR TREATMENT OF COVID-19
#700METHODS FOR TREATING CANCER WITH A WEE1 INHIBITOR
#701Use of sodium dichloroisocyanurate (NaDCC) and a pharmaceutical formulation prepared therefrom
#702METHOD AND SYSTEM FOR APPLYING PULSED ELECTRIC FIELDS WITH HIGH UNIFORMITY USING CHARGED RING STRUCTURES
#703TISSUE DOSING FOR INTRALUMINAL LOCAL DRUG DELIVERY
#704Enhancement of tumor response to chemotherapy by activation of the asmase/ceramide pathway through timed administration of a short-acting anti-angiogenic agent
#705PLANT EXTRACT COMPOSITION FOR THE TREATMENT OF CARDIOVASCULAR AND METABOLIC DISEASES
#706Pharmaceutical composition and use thereof
#707Methods of administration for highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker
#708OXABICYCLOHEPTANES FOR TREATMENT OF SMALL CELL LUNG CANCER
#709USE OF HUMAN EPIDIDYMIS PROTEIN 4 (HE4) FOR ASSESSING RESPONSIVENESS OF MUC 16-POSITIVE CANCER TREATMENT
#710COMBINATION TREATMENT OF LIVER DISEASES USING INTEGRIN INHIBITORS
#711Methods and compositions for increasing the potency of antifungal agents
#712COMPOSITIONS COMPRISING CYANIDIN-3-GALACTOSIDE FOR USE AS VASORELAXANT
#713COMPOSITIONS AND METHODS FOR TREATMENT OF PATHOLOGIC PAIN ASSOCIATED WITH MALIGNANT GROWTH DISORDER
#714Method of treatment of topical dermatologic acne using a cream composition and method of manufacture
#715FORMULATION, COMPOSITION OR FOODSTUFF ADDITIVES FOR THE MODIFICATION OF GLYCEMIC RESPONSE METHODS OF MANUFACTURING AND USING THE SAME
#716HER2 MUTATION INHIBITORS
#717RESIDENCE STRUCTURES AND RELATED METHODS
#718METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS
#719PREPARATION FOR USE AS VASORELAXANT
#720Methods for treating pulmonary non-tuberculous mycobacterial infections
#721COMPOSITION COMPRISING HYDROXYTYROSOL AND PUNICALAGIN FOR USE IN THE TREATMENT OF DYSLIPIDEMIA
#722POLYMORPHS OF TRIAZOLE ANTIFUNGAL COMPOUND PC945
#723Modified zinc oxide nanocomposite, antibiotic composition comprising the same, and combination preparation with the same
#724Specific nutritional or therapeutic agent including a mixture of grape and blueberry
#725PHARMACEUTICAL COMPOSITION FOR ALLEVIATING EYE FATIGUE, CONTAINING, AS ACTIVE INGREDIENTS, LUTEOLIN-7-O-DIGLUCURONIDE AND APIGENIN-7-O-DIGLUCURONIDE ISOLATED FROM PERILLA FRUTESCENS (L.) BRITTON VAR. ACUTA (THUNB.) KUDO LEAF EXTRACT
#726SUSTAINED RELEASE DRUG DELIVERY DEVICE
#727COMPOSITIONS FOR USE AS ANTIOXIDANT
#728Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence
#729Dosage form for use in treating or preventing of a disease
#730ANTIBIOTIC COMPOSITION COMPRISING A COMPOSITE OF DIATOMACEOUS EARTH AND ZINC OXIDE, AND COMBINATION PREPARATION WITH THE SAME
#731DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#732HYBRID AMPHOTERICIN B DERIVATIVES WITH REDUCED TOXICITY
#733Novel Immunodulating Small Molecules
#734NOVEL USES OF CRENOLANIB
#735ANTI-FUNGAL COMPOSITIONS AND METHODS FOR USING SAME
#736Compositions comprising extract for mammalian consumption
#737USE OF MEMBRANE INHIBITORS TO ENHANCE VACCINE DEVELOPMENT AGAINST ENVELOPED VIRUSES
#738USAGE OF EGGSHELL MEMBRANE FOR OBTAINING A FUNCTIONAL RAW MATERIAL AND FOR PURIFICATION OF NATURAL COMPOUNDS AS BIOADSORBENT
#739TOPICAL FORMULATIONS AND INSTILLATES, KITS, AND METHODS FOR TREATING INTEGUMENTARY WOUNDS, AND USES THEREOF
#740SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST, AN SGLT2 INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
#741Derivatives of antibiotics
#742Methods for treating pulmonary non-tuberculous mycobacterial infections
#743Anticancer compounds
#744Method and composition for preventing and treating COVID-19 and long COVID
#745USE OF IODIDE COMPOUNDS FOR THE TREATMENT AND PREVENTION OF CHEMOTHERAPY-ASSOCIATED CACHEXIA AND CARDIOTOXICITY
#746COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND/OR TREATMENT OF DYSBIOSIS AND ANTIBACTERIAL ANTIDOTES FOR MICROBIOME-PROTECTION
#747Compositions and methods for multi-use suppression and acquisition of viruses
#748UREA, AMIDE, AND SUBSTITUTED HETEROARYL COMPOUNDS FOR CBL-B INHIBITION
#749METHODS AND COMPOSITIONS RELATING TO SELECTIVE INTRACELLULAR DELIVERY OF CD38 INHIBITORS
#750TARGETING NONSENSE-MEDIATED DECAY TO ACTIVATE P53 PATHWAY FOR THE TREATMENT OF CANCER
#751TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTIONS
#752COMPOSITION OF PHYTONUTRIENTS FOR OBESITY PREVENTION
#753SPINOSYN FORMULATIONS FOR TREATMENT OF DEMODEX-INDUCED OCULAR AND FACIAL CONDITIONS
#754Compositions and methods of clostridiodides difficile treatment, decolonization, and prevention
#755Use of cannabinoids in the treatment of epilepsy
#756VENETOCLAX DOSING REGIMENS FOR USE IN TREATING MYELODYSPLASTIC SYNDROMES IN COMBINATION WITH A CYP3A INHIBITOR AND AZACITIDINE
#757COMBINED PHARMACEUTICAL COMPOSITION
#758Compositions of Clofazimine, Combinations Comprising Them, Processes for Their Preparation, Uses and Methods of Treatment Comprising Them
#759METHOD FOR INDUCING A SUSTAINED IMMUNE RESPONSE
#760Personalized prediction and identification of the incidence of atrial arrhythmias from other cardiac rhythms
#761COMPOSITIONS AND ARTICLES COMPRISING (NANO)DIAMOND PARTICLES
#762DRUG COMBINATION FOR PREVENTING OR TREATING IRRITABLE BOWEL SYNDROME
#763Method and Compositions for Treating Glioblastoma
#764METHODS OF TREATING LIPEDEMA INCLUDING AKR1C1 AS A THERAPEUTIC TARGET
#765Methods and compositions for treatment of epileptic disorders
#766BIODEGRADABLE DRUG DELIVERY FOR HYDROPHOBIC COMPOSITIONS
#767METHOD FOR IMPROVING SLEEP ONSET AND SLEEP MAINTENANCE, METHOD FOR REDUCING STRESS AND IMPROVING RELAXATION, METHOD FOR IMPROVING PERFORMANCE AND CONCENTRATION, AND METHOD FOR IMPROVING RESTING EFFECT AND PROMOTING RECOVERY FROM FATIGUE
#768Formulations and methods for treating conditions of the eye
#769Subcutaneous delivery of polymer conjugates of therapeutic agents
#770Açai berry seed extract, fractions of açai berry seed extracts, process for obtaining açai berry seed extracts, pharmaceutical and food compositions and method for the treatment of diseases or disorders with açai berry seed extract
#771Treatment of Inflammatory Lesions of Rosacea with Ivermectin
#772COMBINATION TREATMENTS
#773Timosaponin compounds
#774DISSACHARIDE FORMULATIONS FOR CONTROLLED DRUG RELEASE
#775COMPOSITIONS AND METHODS FOR COGNITIVE PROTECTION OF POLLINATORS AGAINST PESTICIDES
#776USE OF ABELMOSCHI COROLLA EXTRACT IN PREPARATION OF DRUG FOR TREATING FIBROSIS
#777Naringin-Loaded Metal Organic Frameworks
#778NUCLEIC ACID-MEDIATED DELIVERY OF THERAPEUTICS
#779TARGETED NANOPARTICLES AND THEIR USES RELATED TO FUNGAL INFECTIONS
#780METHOD OF PREPARING PENTACYCLIC TRITERPENOID SAPONINS AND DRUG COMPOSITION
#781PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCESS FOR THEIR PREPARATION, METHODS FOR TREATING AND USES THEREOF
#782TREATMENT OF SKIN DISORDERS WITH TOPICAL COMBINATION COMPOSITIONS COMPRISING TAPINAROF AND AN ADDITIONAL AHR ACTIVATOR
#783PHARMACEUTICAL ORAL DOSAGE FORMS FOR TREATMENT OF METABOLIC DISORDERS AND RELATED DISEASES THROUGH ORCHESTRATED RELEASE OF ENTEROKINES
#784FUNCTIONAL FOOD
#785Willow extract and its use in treating a viral infection, allergic reaction, and other medical conditions
#786COMPOSITION FOR INHIBITING OSTEOCLASTS CONTAINING AGASTACHE RUGOSA EXTRACT AS ACTIVE INGREDIENT, AND USE THEREOF
#787METHODS OF TREATING DISEASES
#788ANTI-PARASITIC COMPOUNDS FOR THE TREATMENT AND PREVENTION OF VIRAL DISEASES
#789GLYCOSYLATED DIPHYLLIN AS A BROAD-SPECTRUM ANTIVIRAL AGENT AGAINST ZIKA VIRUS AND COVID-19
#790Antiviral supplement formulations
#791SOTORASIB DOSING REGIMEN
#792Methods and compositions for treatment of epileptic disorders
#793SMALL-MOLECULAR ADJUVANTS AND IMPLEMENTATIONS THEREOF
#794Herbal composition for metabolic syndromes and method of treatment thereof
#795METHODS OF TREATING CRYPTOCOCCUS INFECTIONS
#796PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#797INHIBITORS OF ZIKA VIRUS INFECTION
#798SULFUR (VI) FLUORIDE COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF
#799Method of simultaneously treating viral disease caused coronavirus, its variants and mutants using a pharmaceutical micronutrient composition
#800Anti-TMEFF1 antibodies and antibody drug conjugates
#801ANTI-FUNGALS TARGETING THE SYNTHESIS OF FUNGAL SHINGOLIPIDS
#802COMBINATION PRODUCT CONTAINING LIMONOID COMPOUND AND SULFONYLUREA COMPOUND
#803Pemafibrate dosing regimens
#804GENETICALLY MODIFIED HOST CELLS PRODUCING GLYCOSYLATED CANNABINOIDS
#805NOVEL ENTERIC COMBINATION THERAPY
#806Pharmaceutical composition, methods for treating and uses thereof
#807TOPICAL JAK INHIBITOR COMBINATION COMPOSITIONS FOR TREATMENT OF INFLAMMATORY SKIN CONDITIONS
#808PHARMACEUTICAL COMPOSITION AND USES THEREOF
#809Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders
#810PERFORMANCE ENHANCING BEVERAGE
#811ANTI-TUMOR EFFECTIVE COMPONENT OF HEDYOTIS DIFFUSA, PREPARATION METHOD THEREFOR AND USE THEREOF
#8125-heteroaryl-1H-pyrazol-3-amine derivative
#813ASPARTIC PROTEASE-TRIGGERED ANTIFUNGAL HYDROGELS
#814SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST, AN SGLT2 INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
#815Compositions, Methods, and Medical Compositions for Treatment of and Maintaining the Health of the Liver
#816COMPOSITIONS AND METHODS USING A COMBINATION OF CALCIUM AND AT LEAST ONE OF OLEUROPEIN OR METABOLITE THEREOF
#817COMBINATION TREATMENT OF LIVER DISEASES USING FXR AGONISTS
#818METHODS OF TREATING AND DIAGNOSING INFLAMMATORY BOWEL DISEASE
#819Inhibitors and Use Thereof in Cancer Treatment
#820Compositions and methods for supporting immune health
#821PLANT EXTRACT MIXTURE FOR USE IN THE PREVENTION AND/OR TREATMENT OF CHRONIC INFLAMMATORY BOWEL DISEASES
#822Pemafibrate dosing regimens
#823TREATMENT COMPRISING SGLT INHIBITORS
#824EZH2 INHIBITION IN COMBINATION THERAPIES FOR THE TREATMENT OF CANCERS
#825COMPOSITIONS AND METHODS FOR TREATMENT OF HEPATITIS B VIRUS INFECTION
#826Nanoparticles for treatment of posterior segment ocular diseases and conditions
#827COMPOSITIONS AND METHODS USING AT LEAST ONE OF OLEUROPEIN OR A METABOLITE THEREOF TO TREAT OR PREVENT MUSCLE FATIGUE FROM EXERCISE AND/OR FOR RESISTANCE TO MUSCLE FATIGUE FROM EXERCISE
#828Cancer cell-targeted drug delivery carrier and composition for promoting photo-thermal treatment effects, both of which contain M1 macrophages as active ingredient
#829COMPOSITIONS AND METHODS FOR TREATING LUNG, COLORECTAL AND BREAST CANCER
#830ANTI-NEOPLASTIC COMBINED PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
#831METHOD AND COMPOSITION FOR PREVENTING AND TREATING VIRAL INFECTIONS
#832Homodimeric Tobramycin Adjuvant Repurposes Novobiocin as an Effective Antibacterial Agent Against Gram-Negative Bacteria
#833THERAPEUTIC USES OF OXIDISING HYPOTONIC ACID SOLUTIONS
#834HSP90 activator AHA1 drives production of pathological tau aggregates
#835NEURONAL FUNCTION MODULATING AGENT
#836INHALED IVERMECTIN
#837EXTENDED-RELEASE SOLID ORAL DOSAGE FORM COMPRISING VITAMIN B12 AND A VITAMIN B12 DEPLETING DRUG
#838GRAPE PERICARP EXTRACT
#839INHIBITION OF INTERACTION BETWEEN OCT4 AND MAPKAPK2 OR DNA-PKCS TO REGULATE C-MYC IN CANCER
#840ANTIBIOTIC POTENTIATION FOR NONTUBERCULOUS MYCOBACTERIAL DISEASE
#841Enteric combination therapy
#842FINE BAMBOO POWDER AND PREPARATION METHOD THEREFOR AND USE THEREOF
#843PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#844ORALLY ADMINISTRABLE FORMULATIONS FOR THE CONTROLLED RELEASE OF A PHARMACOLOGICALLY ACTIVE AGENT
#845METHOD AND COMBINATION FOR TREATING VIRAL INFECTION AND LONG HAULER SYNDROME
#846COMBINATION PRODUCT CONTAINING LIMONOID COMPOUND AND DPP-4 INHIBITOR
#847MODULATORS OF TELOMERE DISEASE
#848COMPOSITIONS TO PROMOTE THE HEALING OF SKIN ULCERS AND WOUNDS
#849COMPOSITIONS AND METHODS FOR IMPROVING TREATMENT OUTCOMES FOR PATIENTS HAVING HEMATOLOGICAL MALIGNANCIES USING AN EXPANDED STEM CELL PRODUCT
#850Compounds and pharmaceutical uses thereof
#851Endoparasitic depsipeptides
#852PROCESSES AND AGENTS FOR GLAUCOMA
#853COMPOSITIONS AND METHODS USING A COMBINATION OF CALCIUM AND AT LEAST ONE OF OLEUROPEIN OR METABOLITE THEREOF
#854Treatments of prostate cancer
#855MEDICAMENT AND COMBINATION PRODUCT USED FOR PREVENTING, ALLEVIATING AND/OR TREATING FIBROSIS, AND USE THEREOF
#856ALKYL-TPP COMPOUNDS FOR MITOCHONDRIA TARGETING AND ANTI-CANCER TREATMENTS
#857PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#858FORMULATIONS AND METHODS FOR DRUG INSTILLATION INTO THE BLADDER AND TREATMENT OF BLADDER AILMENTS
#859METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY BOWEL DISEASE IN COMPANION ANIMALS
#860BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
#861TRANSDERMAL FORMULATIONS
#862ORAL OCTREOTIDE THERAPY IN COMBINATION WITH DIGOXIN OR LISINOPRIL
#863METHODS OF TREATMENT FOR BACTERIAL INFECTIONS
#864COMPOSITIONS AND METHODS TO TREAT OR PREVENT METABOLIC FATIGUE USING AT THE COMPOUND OLEUROPEIN OR A METABOLITE THEREOF
#865DERMATOLOGICAL FORMULATIONS FOR TREATMENT OF DERMATITIS
#866Method for enhancing beta-adrenergic response
#867Therapeutics and methods for predicting and overcoming endocrine resistance in breast cancer
#868INJECTABLE CLORSULON COMPOSITIONS, METHODS AND USES THEREOF
#869ANTIFUNGAL AGENTS USED IN COMBINATION
#870CANNABINOIDS IN THE TREATMENT OF EPILEPSY
#871Metal oxide encapsulated drug compositions and methods of preparing the same
#872Compound for regulating body weight imbalance, composition thereof and application thereof
#873NANO-PUERARIN REGULATES TUMOR MICROENVIRONMENT AND FACILITATES CHEMO- AND IMMUNOTHERAPY IN MURINE TRIPLE NEGATIVE BREAST CANCER MODEL
#874COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)
#875Methods for treating and Pharmaceutical compositions
#876QUINOLINE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR TREATING EWING'S SARCOMA
#877Preparations containing berry extracts for use in the prophylaxis and/or treatment of viral infections caused by Paramyxoviridae
#878PREPARATIONS CONTAINING BERRY EXTRACTS FOR USE IN TREATING CANCER
#879COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING AND PREVENTING H. PYLORI INFECTIONS
#880Methods Of Treating Metabolic Disorders And Cardiovascular Disease With Inhibin Subunit Beta E (INHBE) Inhibitors
#881Uses of DPP IV inhibitors
#882USE OF CANNABIDIOL IN COMBINATION WITH ANTIBIOTICS
#883Compositions and methods useful in treatment of lower urinary tract symptoms, benign prostatic hyperplasia, erectile dysfunction, and other diseases or symptoms
#884TREATMENT AND PREVENTION OF INFECTIONS BY HERPESVIRIDAE WITH DELPHINIDIN-3-GLUCOSIDE
#885TREATMENT OF ROSACEA WITH TOPICAL COMBINATION COMPOSITIONS
#886COMBINED PREPARATION COMPRISING AN ANTHOCYANIN COMPOSITION AND AN ANTIVIRAL AGENT
#887CANCER THERAPY
#888Mehods and Compositions for Treating SARS-CoV-2 Infection using Carboxyamidotriazole Orotate
#889seed extract composition and its application in antibiotic-resistant infections
#890PROBIOTIC BACTERIA CAPABLE OF ADAPTIVE RESPONSE TO POMEGRANATE EXTRACT AND METHODS OF PRODUCTION AND USE THEREOF
#891USE OF LUTEOLIN-7-O-GLUCOSIDE OR LUTEOLIN-7-O-GLUCURONIDE IN PREPARATION OF MEDICINE FOR EYE INJURIES
#892Method and compositions for treating Coronavirus infection
#893Anthocyanin powder extract and process for production
#894Methods and Compositions for Reducing Side Effects in Chemotherapeutic Treatments
#895FORMULATIONS AND METHODS FOR TREATING CONDITIONS OF THE EYE
#896FUNCTIONALIZED PROSTHETIC INTERFACES FOR THE PREVENTION AND TREATMENT OF DENTAL CONDITIONS
#897Topical Avermectin Formulations and Methods for Elimination and Prophylaxis of Susceptible and Treatment Resistant Strains of Head Lice
#898PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
#899MARKERS OF EFFICACY OF TOPOISOMERASE POISONS
#900TARGETING LASP1, EIF4A1, EIF4B AND CXC4 WITH MODULATORS AND COMBINATIONS THEREOF FOR CANCER THERAPY